Bonzanini C, Ubiali P, Invernizzi R
Divisione di Chirurgia Generale, Ospedale Pesenti-Fenaroli, Alzano Lombardo, Bergamo.
Minerva Chir. 1993 Dec;48(23-24):1437-43.
The authors present a prospective trial in 34 patients undergoing elective colo-rectal surgery. Seventeen patients received 2 g of piperacillin; intravenously, 30' min before surgery, and again 5 times, postoperatively, every 6 hours. The other 17 patients received 2 g of the same drug, intravenously, every 12 hours, immediately after surgery, at least for 5 days. The first group showed postoperative wound infections, with a rate of 11.75%. In the second group 5 patients showed postoperative infection, with a rate of 29.41%. There were 3 wound infections, one urinary tract infection and two pleuropolmonitis (a patient had two infections simultaneously). No side effects were registered. The better results registered in the first group, suggest the use of piperacillin in shortterm prophylaxis. This choice is attractive because of the comparison with other antibiotics, used in a similar way, shows similar results.
作者介绍了一项针对34例行择期结直肠手术患者的前瞻性试验。17例患者在手术前30分钟静脉注射2克哌拉西林,术后每6小时再静脉注射1次,共5次。另外17例患者在术后立即每12小时静脉注射2克相同药物,至少持续5天。第一组术后伤口感染率为11.75%。第二组有5例患者出现术后感染,感染率为29.41%。有3例伤口感染、1例尿路感染和2例胸膜肺炎(1例患者同时发生两种感染)。未记录到副作用。第一组取得的更好结果表明哌拉西林可用于短期预防。由于与以类似方式使用的其他抗生素相比显示出相似结果,这种选择很有吸引力。